Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$3.86M
18 trades · 3 insiders
Net · 90d
$-3.86M
Insiders on file
29
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Philip Ron M | Director | 3 | $0 | $0 | 2026-09-30 |
| Jain Rita | Director | 7 | $0 | $0 | 2026-09-30 |
| Lind Kevin Robert | Director | 6 | $0 | $0 | 2026-09-30 |
| Sullivan Christopher Ryan | Chief Financial Officer | 66 | $3.2K | $5.55M | 2026-09-16 |
| Doyle Mittie | Chief Medical Officer | 69 | $0 | $3.05M | 2026-08-28 |
| Riley Jennifer | Chief Strategy Officer | 7 | $0 | $104.0K | 2026-08-11 |
| VARKI PAUL | Chief Legal Officer | 15 | $0 | $1.51M | 2026-06-10 |
| Truex Samantha | Director | 8 | $0 | $0 | 2026-06-02 |
| KANTOFF AARON | Director | 8 | $0 | $0 | 2026-06-02 |
| Heffernan Michael Thomas | Director | 3 | $0 | $0 | 2026-06-02 |
| KAPLAN GILLA | Director | 15 | $0 | $0 | 2026-06-02 |
| NEIL GARRY ARTHUR | Chief Scientific Officer | 18 | $29.6K | $0 | 2026-05-21 |
| Chan Mitchell | Director | 11 | $0 | $72.5K | 2026-05-06 |
| Goldman Jonathan | Director | 11 | $0 | $163.0K | 2026-03-28 |
| Boyd Taylor | Chief Business Officer | 2 | $0 | $0 | 2026-02-26 |
| Almenoff June Sherie | Director | 17 | $12.8K | $0 | 2025-06-17 |
| Persson Magnus | Director | 10 | $0 | $0 | 2023-12-20 |
| Armistice Capital Master Fund Ltd. | Director, 10% Owner | 7 | $756.6K | $2.16M | 2023-06-27 |
| Caissa Capital Management ltd. | 10% Owner | 34 | $1.68M | $0 | 2023-06-26 |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | 12 | $12.98M | $0 | 2023-02-07 |
| Miller Joseph M | Director | 3 | $0 | $0 | 2022-03-31 |
| Boyd Steven | Director, 10% Owner | 9 | $1.03M | $0 | 2022-03-07 |
| Smolinski Stephen | Chief Commercial Officer | 1 | $0 | $0 | 2022-01-04 |
| Greenway Schond L. | CFO | 1 | $3.5K | $0 | 2021-12-10 |
| Wilkins H Jeffrey | Chief Medical Officer | 1 | $10.0K | $0 | 2021-12-10 |
| Harrell James Archie Jr | Chief Commercial Officer | 1 | $1.7K | $0 | 2021-12-10 |
| COLA MICHAEL F | Chief Executive Officer | 1 | $0 | $0 | 2021-10-01 |
| Gutry Phil | Director | 1 | $0 | $0 | 2021-09-30 |
| Bruhn Suzanne Louise | Director | 1 | $0 | $0 | 2021-09-30 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Philip Ron M | Director | A Award deriv | 2026-09-30 | 2026-10-02 | 1,109 | $12.29 | $13.6K | 1,109 | SEC↗ |
| Jain Rita | Director | A Award deriv | 2026-09-30 | 2026-10-02 | 1,322 | $12.29 | $16.2K | 1,322 | SEC↗ |
| Lind Kevin Robert | Director | A Award deriv | 2026-09-30 | 2026-10-02 | 1,352 | $12.29 | $16.6K | 1,352 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise deriv | 2026-09-16 | 2026-09-18 | 12,394 | — | $0 | 83,848 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-09-16 | 2026-09-18 | 12,394 | $16.33 | $202.4K | 39,900 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2026-09-16 | 2026-09-18 | 12,394 | $9.88 | $122.5K | 52,294 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise deriv | 2026-09-16 | 2026-09-18 | 12,394 | — | $0 | 83,848 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-09-16 | 2026-09-18 | 12,394 | $16.33 | $202.4K | 39,900 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2026-09-16 | 2026-09-18 | 12,394 | $9.88 | $122.5K | 52,294 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise deriv | 2026-09-10 | 2026-09-11 | 10,185 | — | $0 | 105,815 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-09-10 | 2026-09-11 | 10,185 | $17.62 | $179.5K | 39,900 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2026-09-10 | 2026-09-11 | 10,185 | $8.04 | $81.9K | 50,085 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise deriv | 2026-09-10 | 2026-09-11 | 10,185 | — | $0 | 105,815 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-09-10 | 2026-09-11 | 10,185 | $17.62 | $179.5K | 39,900 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2026-09-10 | 2026-09-11 | 10,185 | $8.04 | $81.9K | 50,085 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-08-28 | 2026-09-01 | 679 | — | $0 | 113,734 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-08-28 | 2026-09-01 | 679 | $20.00 | $13.6K | 51,776 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-08-28 | 2026-09-01 | 679 | $8.04 | $5.5K | 52,455 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-08-28 | 2026-09-01 | 679 | — | $0 | 113,734 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-08-28 | 2026-09-01 | 679 | $20.00 | $13.6K | 51,776 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-08-28 | 2026-09-01 | 679 | $8.04 | $5.5K | 52,455 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise deriv | 2026-08-18 | 2026-08-19 | 31,031 | — | $0 | 96,242 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2026-08-18 | 2026-08-19 | 31,031 | $9.88 | $306.6K | 70,931 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-08-18 | 2026-08-19 | 31,031 | $20.05 | $622.2K | 39,900 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise deriv | 2026-08-18 | 2026-08-19 | 31,031 | — | $0 | 96,242 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-08-18 | 2026-08-19 | 31,031 | $20.05 | $622.3K | 39,900 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2026-08-18 | 2026-08-19 | 31,031 | $9.88 | $306.6K | 70,931 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-08-17 | 2026-08-19 | 1,000 | — | $0 | 123,750 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise deriv | 2026-08-17 | 2026-08-19 | 2,876 | — | $0 | 127,273 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise deriv | 2026-08-17 | 2026-08-19 | 37,945 | — | $0 | 130,149 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-08-17 | 2026-08-19 | 1,000 | $12.65 | $12.7K | 52,776 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-08-17 | 2026-08-19 | 1,000 | $20.00 | $20.0K | 51,776 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2026-08-17 | 2026-08-19 | 37,945 | $9.88 | $374.9K | 78,718 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2026-08-17 | 2026-08-19 | 2,876 | $9.88 | $28.4K | 81,594 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-08-17 | 2026-08-19 | 37,945 | $19.85 | $753.2K | 43,649 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-08-17 | 2026-08-19 | 3,749 | $19.94 | $74.8K | 39,900 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-08-17 | 2026-08-19 | 1,000 | — | $0 | 123,750 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-08-17 | 2026-08-19 | 1,000 | $20.00 | $20.0K | 51,776 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-08-17 | 2026-08-19 | 1,000 | $12.65 | $12.7K | 52,776 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise deriv | 2026-08-17 | 2026-08-19 | 2,876 | — | $0 | 127,273 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise deriv | 2026-08-17 | 2026-08-19 | 37,945 | — | $0 | 130,149 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-08-17 | 2026-08-19 | 3,749 | $19.94 | $74.8K | 39,900 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-08-17 | 2026-08-19 | 37,945 | $19.85 | $753.3K | 43,649 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2026-08-17 | 2026-08-19 | 2,876 | $9.88 | $28.4K | 81,594 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2026-08-17 | 2026-08-19 | 37,945 | $9.88 | $374.9K | 78,718 | SEC↗ |
| Riley Jennifer | Chief Strategy Officer | S Sale | 2026-08-11 | 2026-08-12 | 2,655 | $19.59 | $52.0K | 37,041 | SEC↗ |
| Riley Jennifer | Chief Strategy Officer | S Sale | 2026-08-11 | 2026-08-12 | 2,655 | $19.59 | $52.0K | 37,041 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-08-10 | 2026-08-12 | 679 | — | $0 | 114,413 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-08-10 | 2026-08-12 | 679 | $20.00 | $13.6K | 51,776 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-08-10 | 2026-08-12 | 679 | $8.04 | $5.5K | 52,455 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-08-10 | 2026-08-12 | 679 | — | $0 | 114,413 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-08-10 | 2026-08-12 | 679 | $20.00 | $13.6K | 51,776 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-08-10 | 2026-08-12 | 679 | $8.04 | $5.5K | 52,455 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-07-27 | 2026-07-29 | 1,000 | — | $0 | 124,750 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-07-27 | 2026-07-29 | 1,000 | $12.65 | $12.7K | 52,776 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-07-27 | 2026-07-29 | 1,000 | $20.00 | $20.0K | 51,776 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-07-27 | 2026-07-29 | 1,000 | — | $0 | 124,750 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-07-27 | 2026-07-29 | 1,000 | $20.00 | $20.0K | 51,776 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-07-27 | 2026-07-29 | 1,000 | $12.65 | $12.7K | 52,776 | SEC↗ |
| Jain Rita | Director | A Award deriv | 2026-06-30 | 2026-07-02 | 1,080 | $15.04 | $16.2K | 1,080 | SEC↗ |
| Lind Kevin Robert | Director | A Award deriv | 2026-06-30 | 2026-07-02 | 1,105 | $15.04 | $16.6K | 1,105 | SEC↗ |
| Philip Ron M | Director | A Award deriv | 2026-06-30 | 2026-07-02 | 69 | $15.04 | $1.0K | 69 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-06-30 | 2026-07-02 | 2,875 | — | $0 | 125,750 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-06-30 | 2026-07-02 | 1,779 | — | $0 | 115,092 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-06-30 | 2026-07-02 | 4,654 | $20.00 | $93.1K | 51,776 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-06-30 | 2026-07-02 | 1,779 | $8.04 | $14.3K | 56,430 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-06-30 | 2026-07-02 | 2,875 | $12.65 | $36.4K | 54,651 | SEC↗ |
| Philip Ron M | Director | A Award deriv | 2026-06-23 | 2026-06-25 | 40,200 | — | $0 | 40,200 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-06-23 | 2026-06-25 | 1,450 | — | $0 | 116,871 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-06-23 | 2026-06-25 | 1,450 | $8.04 | $11.7K | 53,226 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-06-23 | 2026-06-25 | 1,450 | $18.00 | $26.1K | 51,776 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | F Tax w/h | 2026-06-10 | 2026-06-12 | 1,084 | $13.10 | $14.2K | 51,776 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | F Tax w/h | 2026-06-10 | 2026-06-12 | 138 | $13.10 | $1.8K | 40,773 | SEC↗ |
| VARKI PAUL | Chief Legal Officer | F Tax w/h | 2026-06-10 | 2026-06-12 | 1,081 | $13.10 | $14.2K | 32,576 | SEC↗ |
| Riley Jennifer | Chief Strategy Officer | F Tax w/h | 2026-06-10 | 2026-06-12 | 588 | $13.10 | $7.7K | 39,696 | SEC↗ |
| Jain Rita | Director | A Award deriv | 2026-06-02 | 2026-06-04 | 20,100 | — | $0 | 20,100 | SEC↗ |
| Heffernan Michael Thomas | Director | A Award deriv | 2026-06-02 | 2026-06-04 | 29,500 | — | $0 | 29,500 | SEC↗ |
| KANTOFF AARON | Director | A Award deriv | 2026-06-02 | 2026-06-04 | 20,100 | — | $0 | 20,100 | SEC↗ |
| KAPLAN GILLA | Director | A Award deriv | 2026-06-02 | 2026-06-04 | 20,100 | — | $0 | 20,100 | SEC↗ |
| Lind Kevin Robert | Director | A Award deriv | 2026-06-02 | 2026-06-04 | 20,100 | — | $0 | 20,100 | SEC↗ |
| Truex Samantha | Director | A Award deriv | 2026-06-02 | 2026-06-04 | 20,100 | — | $0 | 20,100 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-05-28 | 2026-06-01 | 679 | — | $0 | 118,321 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-05-28 | 2026-06-01 | 679 | $16.00 | $10.9K | 47,122 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-05-28 | 2026-06-01 | 679 | $8.04 | $5.5K | 47,801 | SEC↗ |
| NEIL GARRY ARTHUR | Chief Executive Officer | A Award | 2026-05-21 | 2026-05-26 | 100,200 | — | $0 | 190,314 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | A Award | 2026-05-21 | 2026-05-26 | 43,500 | — | $0 | 47,122 | SEC↗ |
| VARKI PAUL | Chief Legal Officer | A Award | 2026-05-21 | 2026-05-26 | 24,300 | — | $0 | 27,934 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | A Award | 2026-05-21 | 2026-05-26 | 39,900 | — | $0 | 40,323 | SEC↗ |
| Riley Jennifer | Chief Strategy Officer | A Award | 2026-05-21 | 2026-05-26 | 34,200 | — | $0 | 36,855 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-05-15 | 2026-05-19 | 3,000 | — | $0 | 128,625 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-05-15 | 2026-05-19 | 3,000 | $12.65 | $38.0K | 6,622 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-05-15 | 2026-05-19 | 3,000 | $18.76 | $56.3K | 3,622 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise deriv | 2026-05-07 | 2026-05-11 | 18,606 | — | $0 | 168,094 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2026-05-07 | 2026-05-11 | 18,606 | $9.88 | $183.8K | 19,029 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-05-07 | 2026-05-11 | 18,606 | $24.12 | $448.8K | 423 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-05-06 | 2026-05-07 | 77,905 | — | $0 | 131,625 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-05-06 | 2026-05-07 | 28,650 | — | $0 | 119,000 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise deriv | 2026-05-06 | 2026-05-07 | 47,000 | — | $0 | 116,000 | SEC↗ |
| VARKI PAUL | Chief Legal Officer | M Exercise deriv | 2026-05-06 | 2026-05-07 | 12,563 | — | $0 | 87,437 | SEC↗ |
| VARKI PAUL | Chief Legal Officer | M Exercise deriv | 2026-05-06 | 2026-05-07 | 62,500 | — | $0 | 87,500 | SEC↗ |
| Chan Mitchell | Director | S Sale | 2026-05-06 | 2026-05-07 | 3,167 | $22.88 | $72.5K | 3,166 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-05-06 | 2026-05-07 | 28,650 | $8.04 | $230.3K | 110,177 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-05-06 | 2026-05-07 | 77,905 | $12.65 | $985.5K | 81,527 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-05-06 | 2026-05-07 | 10,058 | $22.88 | $230.1K | 3,622 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-05-06 | 2026-05-07 | 27,538 | $18.03 | $496.5K | 82,639 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-05-06 | 2026-05-07 | 5,000 | $19.65 | $98.3K | 77,639 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-05-06 | 2026-05-07 | 44,944 | $21.20 | $952.8K | 32,695 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-05-06 | 2026-05-07 | 19,015 | $22.41 | $426.1K | 13,680 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2026-05-06 | 2026-05-07 | 47,000 | $8.04 | $377.9K | 47,423 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-05-06 | 2026-05-07 | 13,834 | $18.55 | $256.6K | 33,589 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-05-06 | 2026-05-07 | 8,900 | $22.57 | $200.9K | 423 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-05-06 | 2026-05-07 | 12,347 | $19.28 | $238.1K | 21,242 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-05-06 | 2026-05-07 | 2,700 | $20.76 | $56.1K | 18,542 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-05-06 | 2026-05-07 | 9,219 | $21.37 | $197.0K | 9,323 | SEC↗ |
| VARKI PAUL | Chief Legal Officer | S Sale | 2026-05-06 | 2026-05-07 | 22,839 | $21.22 | $484.6K | 13,287 | SEC↗ |
| VARKI PAUL | Chief Legal Officer | M Exercise | 2026-05-06 | 2026-05-07 | 62,500 | $13.43 | $839.4K | 66,134 | SEC↗ |
| VARKI PAUL | Chief Legal Officer | S Sale | 2026-05-06 | 2026-05-07 | 400 | $23.71 | $9.5K | 3,634 | SEC↗ |
| VARKI PAUL | Chief Legal Officer | S Sale | 2026-05-06 | 2026-05-07 | 9,253 | $22.70 | $210.0K | 4,034 | SEC↗ |
| VARKI PAUL | Chief Legal Officer | S Sale | 2026-05-06 | 2026-05-07 | 5,196 | $19.78 | $102.8K | 36,126 | SEC↗ |
| VARKI PAUL | Chief Legal Officer | S Sale | 2026-05-06 | 2026-05-07 | 37,375 | $18.91 | $706.8K | 41,322 | SEC↗ |
| VARKI PAUL | Chief Legal Officer | M Exercise | 2026-05-06 | 2026-05-07 | 12,563 | $8.04 | $101.0K | 78,697 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-05-05 | 2026-05-07 | 1,000 | — | $0 | 209,530 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-05-05 | 2026-05-07 | 679 | — | $0 | 147,650 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-05-05 | 2026-05-07 | 679 | $8.04 | $5.5K | 5,301 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-05-05 | 2026-05-07 | 1,000 | $12.65 | $12.7K | 4,622 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-05-05 | 2026-05-07 | 1,679 | $16.00 | $26.9K | 3,622 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-04-30 | 2026-05-01 | 8,457 | $13.23 | $111.9K | 423 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-04-29 | 2026-05-01 | 8,458 | $13.09 | $110.7K | 8,880 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-04-06 | 2026-04-08 | 3,970 | — | $0 | 210,530 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-04-06 | 2026-04-08 | 3,970 | $12.65 | $50.2K | 7,592 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-04-06 | 2026-04-08 | 3,970 | $18.01 | $71.5K | 3,622 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-04-02 | 2026-04-03 | 6,200 | $17.02 | $105.5K | 19,118 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-04-02 | 2026-04-03 | 1,780 | $17.57 | $31.3K | 17,338 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-04-01 | 2026-04-03 | 679 | — | $0 | 148,329 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-04-01 | 2026-04-03 | 679 | $16.00 | $10.9K | 3,622 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-04-01 | 2026-04-03 | 679 | $8.04 | $5.5K | 4,301 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-04-01 | 2026-04-03 | 500 | $15.86 | $7.9K | 32,797 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 2026-04-01 | 2026-04-03 | 7,479 | $16.83 | $125.9K | 25,318 | SEC↗ |
| Lind Kevin Robert | Director | A Award deriv | 2026-03-31 | 2026-04-01 | 1,370 | $12.13 | $16.6K | 1,370 | SEC↗ |
| Jain Rita | Director | A Award deriv | 2026-03-31 | 2026-04-01 | 1,339 | $12.13 | $16.2K | 1,339 | SEC↗ |
| Goldman Jonathan | Director | M Exercise deriv | 2026-03-28 | 2026-03-31 | 3,166 | — | $0 | 3,167 | SEC↗ |
| Chan Mitchell | Director | M Exercise deriv | 2026-03-28 | 2026-03-31 | 3,166 | — | $0 | 3,167 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise deriv | 2026-03-28 | 2026-03-31 | 24,200 | — | $0 | 24,200 | SEC↗ |
| NEIL GARRY ARTHUR | Chief Executive Officer | M Exercise deriv | 2026-03-28 | 2026-03-31 | 64,866 | — | $0 | 64,867 | SEC↗ |
| KAPLAN GILLA | Director | M Exercise deriv | 2026-03-28 | 2026-03-31 | 3,166 | — | $0 | 3,167 | SEC↗ |
| KANTOFF AARON | Director | M Exercise deriv | 2026-03-28 | 2026-03-31 | 3,166 | — | $0 | 3,167 | SEC↗ |
| Truex Samantha | Director | M Exercise deriv | 2026-03-28 | 2026-03-31 | 3,166 | — | $0 | 3,167 | SEC↗ |
| Goldman Jonathan | Director | M Exercise | 2026-03-28 | 2026-03-31 | 3,166 | — | $0 | 3,166 | SEC↗ |
| Chan Mitchell | Director | M Exercise | 2026-03-28 | 2026-03-31 | 3,166 | — | $0 | 6,333 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2026-03-28 | 2026-03-31 | 24,200 | — | $0 | 41,538 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | F Tax w/h | 2026-03-28 | 2026-03-31 | 8,241 | $13.89 | $114.5K | 33,297 | SEC↗ |
| NEIL GARRY ARTHUR | Chief Executive Officer | F Tax w/h | 2026-03-28 | 2026-03-31 | 21,892 | $13.89 | $304.1K | 90,114 | SEC↗ |
| NEIL GARRY ARTHUR | Chief Executive Officer | M Exercise | 2026-03-28 | 2026-03-31 | 64,866 | — | $0 | 112,006 | SEC↗ |
| KAPLAN GILLA | Director | M Exercise | 2026-03-28 | 2026-03-31 | 3,166 | — | $0 | 6,333 | SEC↗ |
| KANTOFF AARON | Director | M Exercise | 2026-03-28 | 2026-03-31 | 3,166 | — | $0 | 6,333 | SEC↗ |
| Truex Samantha | Director | M Exercise | 2026-03-28 | 2026-03-31 | 3,166 | — | $0 | 6,333 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-03-16 | 2026-03-18 | 5,992 | — | $0 | 149,008 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise deriv | 2026-03-16 | 2026-03-18 | 19,500 | — | $0 | 214,500 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | S Sale | 2026-03-16 | 2026-03-18 | 25,492 | $16.15 | $411.7K | 3,622 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-03-16 | 2026-03-18 | 5,992 | $8.04 | $48.2K | 29,114 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | M Exercise | 2026-03-16 | 2026-03-18 | 19,500 | $12.65 | $246.7K | 23,122 | SEC↗ |
| NEIL GARRY ARTHUR | Chief Executive Officer | A Award deriv | 2026-02-26 | 2026-03-02 | 286,000 | — | $0 | 286,000 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | A Award deriv | 2026-02-26 | 2026-03-02 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Boyd Taylor | Chief Business Officer | A Award deriv | 2026-02-26 | 2026-03-02 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | A Award deriv | 2026-02-26 | 2026-03-02 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Riley Jennifer | Chief Strategy Officer | A Award deriv | 2026-02-26 | 2026-03-02 | 95,000 | — | $0 | 95,000 | SEC↗ |
| VARKI PAUL | Chief Legal Officer | A Award deriv | 2026-02-26 | 2026-03-02 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Jain Rita | Director | A Award deriv | 2025-12-31 | 2026-01-05 | 1,043 | $14.74 | $15.4K | 1,043 | SEC↗ |
| Lind Kevin Robert | Director | A Award deriv | 2025-12-31 | 2026-01-05 | 848 | $14.74 | $12.5K | 848 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | F Tax w/h | 2025-12-10 | 2025-12-12 | 155 | $4.10 | $636 | 17,338 | SEC↗ |
| VARKI PAUL | Chief Legal Officer | F Tax w/h | 2025-12-10 | 2025-12-12 | 1,016 | $4.10 | $4.2K | 3,634 | SEC↗ |
| Riley Jennifer | Chief Strategy Officer | F Tax w/h | 2025-12-10 | 2025-12-12 | 637 | $4.10 | $2.6K | 2,655 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | F Tax w/h | 2025-12-10 | 2025-12-12 | 1,013 | $4.10 | $4.2K | 3,622 | SEC↗ |
| Goldman Jonathan | Director | M Exercise deriv | 2025-11-14 | 2025-11-17 | 8,200 | — | $0 | 16,400 | SEC↗ |
| Goldman Jonathan | Director | S Sale | 2025-11-14 | 2025-11-17 | 3,167 | $14.30 | $45.3K | 0 | SEC↗ |
| Goldman Jonathan | Director | M Exercise | 2025-11-14 | 2025-11-17 | 8,200 | $9.88 | $81.0K | 8,200 | SEC↗ |
| Goldman Jonathan | Director | S Sale | 2025-11-14 | 2025-11-17 | 8,200 | $14.35 | $117.7K | 0 | SEC↗ |
| Lind Kevin Robert | Director | A Award deriv | 2025-10-01 | 2025-10-02 | 40,200 | — | $0 | 40,200 | SEC↗ |
| Boyd Taylor | Chief Business Officer | A Award deriv | 2025-10-01 | 2025-10-06 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Jain Rita | Director | A Award deriv | 2025-09-30 | 2025-10-02 | 1,572 | — | $0 | 1,572 | SEC↗ |
| Jain Rita | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 40,200 | — | $0 | 40,200 | SEC↗ |
| Almenoff June Sherie | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 20,100 | — | $0 | 20,100 | SEC↗ |
| Heffernan Michael Thomas | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 29,500 | — | $0 | 29,500 | SEC↗ |
| KANTOFF AARON | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 20,100 | — | $0 | 20,100 | SEC↗ |
| KAPLAN GILLA | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 20,100 | — | $0 | 20,100 | SEC↗ |
| Goldman Jonathan | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 20,100 | — | $0 | 20,100 | SEC↗ |
| Chan Mitchell | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 20,100 | — | $0 | 20,100 | SEC↗ |
| Truex Samantha | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 20,100 | — | $0 | 20,100 | SEC↗ |
| NEIL GARRY ARTHUR | Chief Executive Officer | M Exercise deriv | 2025-03-28 | 2025-04-01 | 64,867 | — | $0 | 129,733 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise deriv | 2025-03-28 | 2025-04-01 | 24,200 | — | $0 | 48,400 | SEC↗ |
| Almenoff June Sherie | Director | M Exercise deriv | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 6,333 | SEC↗ |
| KAPLAN GILLA | Director | M Exercise deriv | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 6,333 | SEC↗ |
| KANTOFF AARON | Director | M Exercise deriv | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 6,333 | SEC↗ |
| Truex Samantha | Director | M Exercise deriv | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 6,333 | SEC↗ |
| Goldman Jonathan | Director | M Exercise deriv | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 6,333 | SEC↗ |
| Chan Mitchell | Director | M Exercise deriv | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 6,333 | SEC↗ |
| NEIL GARRY ARTHUR | Chief Executive Officer | M Exercise | 2025-03-28 | 2025-04-01 | 64,867 | — | $0 | 64,927 | SEC↗ |
| NEIL GARRY ARTHUR | Chief Executive Officer | F Tax w/h | 2025-03-28 | 2025-04-01 | 17,787 | $8.46 | $150.5K | 47,140 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2025-03-28 | 2025-04-01 | 24,200 | — | $0 | 24,206 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | F Tax w/h | 2025-03-28 | 2025-04-01 | 7,285 | $8.46 | $61.6K | 16,921 | SEC↗ |
| Almenoff June Sherie | Director | M Exercise | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 3,167 | SEC↗ |
| KAPLAN GILLA | Director | M Exercise | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 3,167 | SEC↗ |
| KANTOFF AARON | Director | M Exercise | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 3,167 | SEC↗ |
| Truex Samantha | Director | M Exercise | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 3,167 | SEC↗ |
| Goldman Jonathan | Director | M Exercise | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 3,167 | SEC↗ |
| Chan Mitchell | Director | M Exercise | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 3,167 | SEC↗ |
| Heffernan Michael Thomas | Director | A Award deriv | 2025-03-25 | 2025-03-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | A Award deriv | 2025-01-28 | 2025-01-30 | 155,000 | — | $0 | 155,000 | SEC↗ |
| NEIL GARRY ARTHUR | CEO and Chairman of the Boar | A Award deriv | 2025-01-28 | 2025-01-30 | 411,000 | — | $0 | 411,000 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | A Award deriv | 2025-01-28 | 2025-01-30 | 163,000 | — | $0 | 163,000 | SEC↗ |
| VARKI PAUL | Chief Legal Officer | A Award deriv | 2025-01-28 | 2025-01-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Riley Jennifer | Chief Strategy Officer | A Award deriv | 2025-01-01 | 2025-01-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Almenoff June Sherie | Director | P Buy | 2024-11-13 | 2024-11-14 | 500 | $13.00 | $6.5K | 1,000 | SEC↗ |
| Almenoff June Sherie | Director | P Buy | 2024-11-12 | 2024-11-14 | 500 | $12.50 | $6.3K | 500 | SEC↗ |
| NEIL GARRY ARTHUR | CEO and Chairman of the Boar | A Award deriv | 2024-08-13 | 2024-08-14 | 500,400 | — | $0 | 500,400 | SEC↗ |
| NEIL GARRY ARTHUR | CEO and Chairman of the Boar | A Award deriv | 2024-08-13 | 2024-08-14 | 194,600 | — | $0 | 194,600 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | A Award deriv | 2024-08-13 | 2024-08-14 | 72,600 | — | $0 | 72,600 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | A Award deriv | 2024-08-13 | 2024-08-14 | 186,700 | — | $0 | 186,700 | SEC↗ |
| KAPLAN GILLA | Director | A Award deriv | 2024-08-13 | 2024-08-14 | 24,600 | — | $0 | 24,600 | SEC↗ |
| KAPLAN GILLA | Director | A Award deriv | 2024-08-13 | 2024-08-14 | 9,500 | — | $0 | 9,500 | SEC↗ |
| Truex Samantha | Director | A Award deriv | 2024-08-13 | 2024-08-14 | 24,600 | — | $0 | 24,600 | SEC↗ |
| Truex Samantha | Director | A Award deriv | 2024-08-13 | 2024-08-14 | 9,500 | — | $0 | 9,500 | SEC↗ |
| KANTOFF AARON | Director | A Award deriv | 2024-08-13 | 2024-08-14 | 24,600 | — | $0 | 24,600 | SEC↗ |
| KANTOFF AARON | Director | A Award deriv | 2024-08-13 | 2024-08-14 | 9,500 | — | $0 | 9,500 | SEC↗ |
| Almenoff June Sherie | Director | A Award deriv | 2024-08-13 | 2024-08-14 | 9,500 | — | $0 | 9,500 | SEC↗ |
| Almenoff June Sherie | Director | A Award deriv | 2024-08-13 | 2024-08-14 | 24,600 | — | $0 | 24,600 | SEC↗ |
| Chan Mitchell | Director | A Award deriv | 2024-08-13 | 2024-08-14 | 9,500 | — | $0 | 9,500 | SEC↗ |
| Chan Mitchell | Director | A Award deriv | 2024-08-13 | 2024-08-14 | 24,600 | — | $0 | 24,600 | SEC↗ |
| Goldman Jonathan | Director | A Award deriv | 2024-08-13 | 2024-08-14 | 9,500 | — | $0 | 9,500 | SEC↗ |
| Goldman Jonathan | Director | A Award deriv | 2024-08-13 | 2024-08-14 | 24,600 | — | $0 | 24,600 | SEC↗ |
| Doyle Mittie | Chief Medical Officer | A Award deriv | 2024-07-15 | 2024-07-16 | 234,000 | — | $0 | 234,000 | SEC↗ |
| VARKI PAUL | Chief Legal Officer | A Award deriv | 2024-06-24 | 2024-06-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Chan Mitchell | Director | A Award deriv | 2023-12-20 | 2023-12-21 | 3,334 | — | $0 | 3,334 | SEC↗ |
| KAPLAN GILLA | Director | A Award deriv | 2023-12-20 | 2023-12-21 | 3,334 | — | $0 | 3,334 | SEC↗ |
| Almenoff June Sherie | Director | A Award deriv | 2023-12-20 | 2023-12-21 | 3,334 | — | $0 | 3,334 | SEC↗ |
| Persson Magnus | Director | A Award deriv | 2023-12-20 | 2023-12-21 | 3,334 | — | $0 | 3,334 | SEC↗ |
| Almenoff June Sherie | Director | A Award deriv | 2023-06-30 | 2023-07-05 | 4,575 | — | $0 | 4,575 | SEC↗ |
| Persson Magnus | Director | A Award deriv | 2023-06-30 | 2023-07-05 | 28,308 | — | $0 | 28,308 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | S Sale | 2023-06-27 | 2023-06-28 | 937,404 | $0.52 | $487.5K | 731,458 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-06-26 | 2023-06-27 | 182,300 | $0.62 | $113.0K | 0 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-06-26 | 2023-06-27 | 1,425,700 | $0.64 | $912.4K | 0 | SEC↗ |
| Armistice Capital Master Fund | 10% Owner | S Sale | 2023-06-26 | 2023-06-28 | 2,746,138 | $0.61 | $1.68M | 1,668,862 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-06-20 | 2023-06-20 | 2,000 | $4.14 | $8.3K | 1,425,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-06-16 | 2023-06-20 | 3,000 | $3.90 | $11.7K | 1,423,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-06-15 | 2023-06-20 | 3,160 | $3.68 | $11.6K | 1,420,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-06-14 | 2023-06-14 | 6,000 | $3.48 | $20.9K | 1,417,540 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-06-13 | 2023-06-14 | 8,750 | $3.82 | $33.4K | 1,411,540 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-06-12 | 2023-06-14 | 2,149 | $4.34 | $9.3K | 1,402,790 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-06-09 | 2023-06-09 | 5,044 | $4.14 | $20.9K | 1,400,641 | SEC↗ |
| NEIL GARRY ARTHUR | CEO and Chairman of the Boar | P Buy | 2023-06-09 | 2023-06-13 | 4,000 | $3.42 | $13.7K | 13,220 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | P Buy | 2023-06-09 | 2023-06-13 | 511 | $3.42 | $1.7K | 1,262 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-06-08 | 2023-06-09 | 6,398 | $3.93 | $25.1K | 1,395,597 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-06-07 | 2023-06-09 | 2,984 | $3.49 | $10.4K | 1,389,199 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-05-31 | 2023-06-02 | 844 | $2.87 | $2.4K | 1,386,215 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-05-30 | 2023-05-30 | 671 | $2.87 | $1.9K | 1,385,371 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-05-25 | 2023-05-30 | 2,000 | $2.77 | $5.5K | 1,384,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-05-24 | 2023-05-24 | 5,519 | $2.96 | $16.3K | 1,382,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-05-24 | 2023-05-24 | 3,481 | $3.01 | $10.5K | 1,377,181 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-05-22 | 2023-05-22 | 7,000 | $3.34 | $23.4K | 1,373,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-05-19 | 2023-05-22 | 6,500 | $3.52 | $22.9K | 1,366,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-05-18 | 2023-05-22 | 13,121 | $3.29 | $43.2K | 1,360,200 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-05-16 | 2023-05-16 | 379 | $2.75 | $1.0K | 1,347,079 | SEC↗ |
| NEIL GARRY ARTHUR | CEO and Chairman of the Boar | A Award deriv | 2023-05-15 | 2023-05-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | A Award deriv | 2023-05-15 | 2023-05-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-05-15 | 2023-05-16 | 1,715 | $2.55 | $4.4K | 1,346,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-05-12 | 2023-05-16 | 2,285 | $2.45 | $5.6K | 1,344,985 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-05-08 | 2023-05-08 | 5,000 | $2.62 | $13.1K | 1,342,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-05-05 | 2023-05-08 | 5,000 | $2.88 | $14.4K | 1,337,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-05-04 | 2023-05-08 | 15,000 | $2.79 | $41.9K | 1,332,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-04-27 | 2023-04-27 | 1,504 | $2.96 | $4.5K | 1,317,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-04-26 | 2023-04-27 | 425 | $2.97 | $1.3K | 1,316,196 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-04-25 | 2023-04-27 | 5,571 | $3.00 | $16.7K | 1,315,771 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-04-24 | 2023-04-24 | 12,500 | $3.06 | $38.3K | 1,310,200 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-04-20 | 2023-04-24 | 5,000 | $3.08 | $15.4K | 1,297,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-04-18 | 2023-04-18 | 10,000 | $2.94 | $29.4K | 1,292,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-04-17 | 2023-04-18 | 15,000 | $2.96 | $44.4K | 1,282,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-04-11 | 2023-04-11 | 25,000 | $2.84 | $71.0K | 1,267,700 | SEC↗ |
| Caissa Capital Management ltd. | 10% Owner | P Buy | 2023-04-10 | 2023-04-11 | 31,329 | $2.28 | $71.4K | 1,242,700 | SEC↗ |
| Persson Magnus | Director | A Award deriv | 2023-03-31 | 2023-04-04 | 7,222 | — | $0 | 7,222 | SEC↗ |
| Almenoff June Sherie | Director | A Award deriv | 2023-03-31 | 2023-04-04 | 1,167 | — | $0 | 1,167 | SEC↗ |
| NEIL GARRY ARTHUR | CEO and Chairman of the Boar | A Award deriv | 2023-02-13 | 2023-02-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | A Award deriv | 2023-02-13 | 2023-02-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ARMISTICE CAPITAL, LLC | 10% Owner | P Buy deriv | 2023-02-07 | 2023-02-09 | 450,000 | — | $0 | 450,000 | SEC↗ |
| ARMISTICE CAPITAL, LLC | 10% Owner | P Buy | 2023-02-07 | 2023-02-09 | 450,000 | — | $0 | 4,415,000 | SEC↗ |
| ARMISTICE CAPITAL, LLC | 10% Owner | L Small acq | 2023-02-03 | 2023-02-09 | 334 | $3.95 | $1.3K | 3,965,000 | SEC↗ |
| Almenoff June Sherie | Director | A Award deriv | 2022-12-30 | 2023-01-03 | 410 | — | $0 | 410 | SEC↗ |
| Persson Magnus | Director | A Award deriv | 2022-12-30 | 2023-01-03 | 2,536 | — | $0 | 2,536 | SEC↗ |
| NEIL GARRY ARTHUR | CEO and Chairman of the Boar | P Buy | 2022-12-09 | 2022-12-12 | 2,083 | $4.42 | $9.2K | 9,220 | SEC↗ |
| Sullivan Christopher Ryan | Chief Financial Officer | A Award deriv | 2022-10-05 | 2022-10-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NEIL GARRY ARTHUR | CEO and Chairman of the Boar | A Award deriv | 2022-10-05 | 2022-10-07 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Persson Magnus | Director | A Award deriv | 2022-09-30 | 2022-10-03 | 3,747 | — | $0 | 3,747 | SEC↗ |
| KAPLAN GILLA | Director | A Award deriv | 2022-09-30 | 2022-10-03 | 3,080 | — | $0 | 3,080 | SEC↗ |
| Almenoff June Sherie | Director | A Award deriv | 2022-09-30 | 2022-10-03 | 605 | — | $0 | 605 | SEC↗ |
| Almenoff June Sherie | Director | A Award deriv | 2022-06-30 | 2022-07-01 | 4,338 | — | $0 | 4,338 | SEC↗ |
| KAPLAN GILLA | Director | A Award deriv | 2022-06-30 | 2022-07-01 | 44,115 | — | $0 | 44,115 | SEC↗ |
| Persson Magnus | Director | A Award deriv | 2022-06-30 | 2022-07-05 | 26,837 | — | $0 | 26,837 | SEC↗ |
| Almenoff June Sherie | Director | A Award deriv | 2022-06-14 | 2022-06-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Chan Mitchell | Director | A Award deriv | 2022-06-14 | 2022-06-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KAPLAN GILLA | Director | A Award deriv | 2022-06-14 | 2022-06-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Persson Magnus | Director | A Award deriv | 2022-06-14 | 2022-06-16 | 40,000 | — | $0 | 40,000 | SEC↗ |